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Pseudomonas aeruginosa biofilms are implicated in 
chronic infections. A key element of P. aeruginosa 
pathogenicity is the formation of a biofilm, a 
community of bacteria encased in an exopolymeric 
substance (EPS) that shields the bacteria from the 
host immune response and antibiotic treatment. A 
crucial step in biofilm production is a switch in 
motility from freely swimming, planktonic bacteria 
to twitching movement and then to attached and 
sedentary bacteria that develop into a mature 
pillar-shaped biofilm. A mucoid biofilm produces 
an excess of alginate and is clinically the most 
pathogenic and the most resistant to antibiotics. 
Biofilms from patients exhibit a wide variety of 
structure, motility, and levels of attachment. In vitro 
biofilms do not exhibit such a wide variety of 
structure and physiology. The difference between in 
vivo and in vitro biofilms has made the translation 
of in vitro studies into in vivo treatments difficult.  
Under different growth conditions in our lab, 
the P. aeruginosa strain PAO1 demonstrates two 
phenotypes:  a non-mucoid and a mucoid-like 
phenotype. Confocal laser scanning microscopy 
(CLSM) indicates the mucoid-like phenotype 
is intermediate in height to the non-mucoid 
phenotype and biofilms formed in a once-flow-
through chamber.  Both mucoid-like and non-
mucoid phenotypes exhibit a significant increase in 
twitching between 24 and 72 hours of development. 
The mucoid-like phenotype had greater attachment 
at 72 hours compared to non-mucoid phenotype. 
Therefore, the two phenotypes observed in our lab 
may represent the effect of environment to stimulate 
development of two types of biofilms by PAO1.
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Pseudomonas aeruginosa (PA) is an op-
portunistic pathogen implicated in chronic 
infections in cystic fibrosis (CF) (15, 17, 33) 
and chronic wounds (4, 8, 17). Its virulence 
is due, in part, to formation of biofilms 
which confer resistance to both the innate 
immune system and antibiotics. Biofilms 
recovered from the sputum of CF patients 
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can exhibit a widespread variability in 
biofilm formation both in structure and 
virulence (1, 10, 27, 33).
BIOFILM FORMATION
Biofilms are understood to have several 
steps in their formation (8, 33). There is an 
initial attachment to a surface followed by 
microcolony formation. The biofilm may 
then mature to a pillar-shaped structure 
which can release planktonic (freely mov-
ing) bacteria to colonize new areas. Inside 
biofilms, cells in different regions exhibit 
differences in gene expression as well as 
functional heterogeneity, indicating a com-
plex community of cells within biofilms 
(8). The time span for the formation of a 
pillar-shaped biofilm depends on many 
factors, but has been estimated to take 5-7 
days at minimum (33).
The triggers for biofilm formation are 
complex, but one trigger is the formation 
of a quorum sensing (QS) signaling cas-
cade.  One QS molecule, N-(3-oxodo-deca-
noyl)-L-homoserine lactone (3OC12-HSL) 
is constitutively released from P. aerugi-
nosa. When P. aeruginosa has multiplied 
and reached a large enough population 
(i.e. a “quorum”), 3OC12-HSL levels reach 
a threshold and signal extensive changes 
in gene expression through the LasR-LasI 
system (8, 9, 28, 33). One of these chang-
es includes the formation of a second 
QS molecule, N-butyryl-L-homoserine 
lactone (C4-HSL). C4-HSL acts through 
the RhlR-RhlI system independently and 
in a coordinated fashion with 3OC12-HSL 
further influences gene expression. In fact, 
blocking QS molecule action has been one 
target of therapeutic interventions, but 
with limited success (2).
 
 
EXOPOLYMERIC 
SUBSTANCE (EPS)
Biofilm maturation requires the formation of 
an exopolymeric substance (EPS) which con-
fers antibiotic resistance and protection from 
host immunity by the biofilm (4, 8, 33). The 
EPS in a P. aeruginosa biofilm is composed 
of three components: alginate, Psl, and Pel, al-
though other polymers such as certain proteins, 
lipids, and extracellular DNA also contribute to 
biofilm structure (12, 24, 25, 36). 
Psl, composed of rhamnose, mannose, and 
glucose, is required for maintenance of any 
biofilm structure, and for biofilm construc-
tion (31, 36). Overproduction of Psl promotes 
mushroom-shaped biofilms (36). Pel, a glu-
cose-rich component of the EPS, is required 
for initiation of any biofilm, as well as for the 
growth of air-liquid interface biofilms (31, 36). 
The final EPS component, alginate, is a com-
plex polysaccharide composed of two different 
sugars, ß-D-mannuronate and L-glucuronate, 
and is one of the most studied and well under-
stood portions of the matrix.  Over-expression 
of alginate causes what has been termed the 
mucoid biofilm phenotype for its mucus-like 
appearance (31). Mucoid biofilms have been 
shown to be more virulent and are often 
found in chronic infections (11, 23). Mutant 
strains of P. aeruginosa which produce mucoid 
biofilms can be studied in vitro; however, the 
transformation of wild-type P. aeruginosa into 
a mucoid biofilm is not well understood (7). 
Because of the homogeneity of in vitro bio-
films grown in the laboratory setting and the 
heterogeneity of in vivo biofilms as recovered 
from CF patients, it has been difficult to study 
these pathogenic mucoid biofilms within the 
lab. 
This heterogeneity of biofilms recovered 
from CF patients is well documented. They 
differ structurally as demonstrated 
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in scanning electron microscopy as pil-
lar-shaped, knobby, or flat (10). The PAO1 
within biofilms are also functionally dis-
tinct as seen in the QS molecules released, 
their virulence, the types of motility they 
exhibit, their ability to attach to a surface, 
and their response to treatment (1, 27, 33). 
In recent years several strategies have been 
employed to characterize P. aeruginosa 
isolates from patients in order to identi-
fy the most effective treatment. Virulent 
strains of P. aeruginosa form biofilms, but 
also have decreased motility and decreased 
production of virulence factors such as 
pyocyanin (1, 27). It has been hypothesized 
that a lack of production of flagella or type 
IV pili might help P. aeruginosa evade 
the host immune system since both innate 
and adaptive immune systems respond to 
epitopes on flagella and type IV pili (1, 27). 
A lack of motility may also increase the 
ability of P. aeruginosa to attach to a sur-
face and produce a biofilm. These studies 
also demonstrated a decrease in production 
of virulence factors such as pyocyanin 
(1, 27). Virulence factors are common in 
acute infection and may spur the immune 
system response. Therefore, eradicating or 
decreasing the production of virulence 
factors may decrease stimulation of the 
host immune system by P. aeruginosa, 
increasing the ability of P. aeruginosa to 
evade the host immune response. Finally, 
the production of biofilms increases the 
ability of P. aeruginosa to evade the host 
immune system by creating the exopoly-
saccharide (EPS) matrix that limits the 
ability of the host immune system to reach 
P. aeruginosa. 
Clinical isolates of P. aeruginosa biofilms 
can be classified by their motility patterns 
and biofilm structure (1, 10, 27). Mulet 
et al. (2013) demonstrated that high risk 
clones of P. aeruginosa from CF sputum 
contained greater drug resistance as well 
as increased biofilm production, decreased 
twitching, and decreased production of 
pyoverdine and pyocyanin, two virulence 
factors. Therefore, changes in motility from 
swimming to swarming to twitching are 
a standard part of the formation of bio-
films. These changes allow P. aeruginosa 
to attach to a surface, form a microcolony, 
and finally, form a biofilm. However, the 
emerging clinical picture indicates that 
motility patterns are being used to classi-
fy and characterize clinical isolates based 
on their virulence and ability to develop 
chronic infections (10, 27). In the clinical 
setting then, motility may not only serve 
a role in biofilm formation, but may also 
serve as an additional marker that may 
lead to identification of the most effective 
methods for treatment of chronic P. aeru-
ginosa infections.
MOTILITY
P. aeruginosa exhibits swimming, swarm-
ing, and twitching types of motility. 
Twitching is mediated by type IV pili 
which act as retractable arms that can 
pull or “slingshot” cells across a surface 
(5, 19). Twitching is usually seen in more 
viscous types of media or environments. 
Swimming through a liquid medium is 
performed by the use of flagella (18, 36). 
Swarming movements use both type IV 
pili and flagella resulting in a movement 
in between swimming and twitching (14, 
36). To test motility, assays are used mea-
suring distance displaced by P. aeruginosa 
on plates of media with different fluidity 
(5, 10). 
As previously stated, the motility of  P. 
aeruginosa within a biofilm can be used to 
identify virulent strains that are more like-
ly to cause chronic infection. However, the 
correlation between motility and its role 
in biofilm formation is not entirely clear. 
Swimming motility may not be required 
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for biofilm formation, but may be import-
ant in allowing P. aeruginosa to reach an 
environment with greater nutrients or to 
colonize a new area (36). Therefore, al-
though it may not be directly involved in 
the stage of biofilm formation, swimming 
motility may play a role in determining 
sites where P. aeruginosa can travel to 
form a biofilm.  
Perhaps the most critical type of motility 
for P. aeruginosa during biofilm forma-
tion is the ability to twitch. This is how 
bacteria move on a solid surface, perhaps 
as they are attaching to a surface to form 
a microcolony (10, 36, 37).  Psl may be 
secreted to coat a solid surface as bacte-
ria twitch in a spider web fashion. Other 
bacteria then attach to this surface to form 
a microcolony, which is one of the first 
steps in biofilm formation (36, 37). There 
is evidence that bacteria favor the use of 
flagella to swim or type IV pili to twitch; 
once there is a switch to a different type 
of movement, it may be difficult for the 
bacteria to revert to the previous type of 
motility (35). 
Swarming, which uses both flagella and 
type IV pili, may represent P. aeruginosa 
in transition from swimming to attach-
ment in which twitching will then pre-
dominate. Originally, research indicated 
that swarming is only mediated by flagella 
(10); however, more recent data indicate the 
use of both flagella and type IV pili are 
required (5, 36). Therefore, swarming may 
be an intermediate form of motility for 
P. aeruginosa between swimming which 
requires only flagella and twitching which 
requires only type IV pili. In fact, data 
indicate that bacteria can twitch or swim, 
but rarely do both well (35), indicating 
that modes of motility vary according to 
stimuli.
TWO PHENOTYPES 
OF PAO1 DEVELOP 
UNDER DIFFERENT 
ENVIRONMENTAL 
CONDITIONS
PAO1 is a strain of P. aeruginosa common-
ly used in laboratory experiments. We 
have been able to grow PAO1 in our lab 
with two distinct phenotypes, which have 
named non-mucoid and “mucoid-like” 
phenotypes. We wanted to investigate 
the differences in structure, motility, and 
surface attachment between these two 
phenotypes. It is our hypothesis that PAO1 
in the mucoid-like phenotype produce a 
biofilm closer to a “mucoid” biofilm with 
greater twitching motility, greater attach-
ment to a surface, and greater height and 
pillar-shaped structure, when compared to 
the non-mucoid phenotype of PAO1. 
To investigate these two phenotypes we 
used confocal scanning laser microscopy, 
motility assays, and a surface attachment 
assay. If the mucoid-like phenotype ex-
hibits greater twitching behavior, surface 
attachment, and more pillar-shaped mor-
phology than the non-mucoid biofilm, 
these environmental conditions may be 
replicated to study different phenotypes of 
PAO1 biofilms.
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MATERIALS AND METHODS
GROWTH OF MUCOID-
LIKE AND NON-MUCOID 
CULTURES:
PAO1 (ATTC BAA-47) cultures were grown 
overnight in 10 ml tryptic soy broth (TSB) 
(Difco Laboratories, Sparks, MD) in standard 16 
ml  glass test tubes with a plastic cap (VWR, 
89000-482) before being streaked for isolation 
on tryptic soy agar (TSA) plates (Difco Lab-
oratories, Sparks, MD).  Single colonies were 
used to inoculate TSB under two environ-
mental conditions to produce biofilms with 
either mucoid-like or non-mucoid phenotypes. 
Mucoid-like phenotype PAO1 biofilms were 
grown in 10 ml TSB in standard 16 ml glass 
test tubes with a plastic cap (VWR, 89000-
482) on a shaker incubator at 37°C and 225 
RPM.  Non-mucoid phenotype PAO1 biofilms 
were grown in a 250 ml Erlenmeyer flask 
(VWR, 29136-060) with 100 ml TSB and a foil 
cap at the same conditions.  The shaking was 
set so that the biofilms did not grow on the 
surface of the culture or on a solid surface, but 
throughout the media. The two phenotypes 
were easily distinguished. The mucoid-like 
phenotype developed strings of a mucous-like 
substance that spun down toward the bottom 
of the test tube. The shaking was necessary 
to keep the mucoid-like strings suspended 
in the TSB and maintain oxygenation of the 
TSB. Without shaking, the mucoid-like strings 
of biofilm sank to the bottom of the test tube 
and died (data not shown). The non-mucoid 
biofilms developed a thick, consistent composi-
tion throughout the TSB. Previous studies have 
implicated nutrient or oxygen deprivation 
in initiating biofilm formation (13, 16, 32, 34). 
Samples were grown for 24, 48, or 72-hour 
time periods. 
GROWTH OF BIOFILMS 
USING ONCE FLOW 
THROUGH CHAMBERS:
Mature biofilms are most fully developed 
in vitro in a flow cell apparatus with a con-
stant flow of media over the biofilm. As a 
positive control for biofilm development,  a 
three-chambered flow cell apparatus (IBI 
Scientific, Peosta, IA) was set up as previously 
described (6, 24). TSB at room temperature 
was pumped through the individual chambers 
at a rate of 2.5 ml/minute.  Prior to inoculation 
of the apparatus chambers, a single colony of 
PAO1 was inoculated into 10ml TSB overnight 
at 37°C. The 10 ml sample was diluted until 
an absorbance of 0.5 at OD600 was reached 
using a protocol outlined in Deligianni et al. 
(10). Each chamber was inoculated with 0.5 ml 
of the diluted sample.  During the inoculation 
period, chambers were inverted and flow 
was stopped for one hour while bacterial cells 
were given time to attach (6). Each of the three 
chambers was assigned to a 24, 48, or 72 hour 
sample. One chamber was inoculated each 
day for three days. All three chambers were 
stopped on the same day, 24 hours after the 
inoculation of the final chamber. Biofilms were 
first fixed with 100 ml of 4% paraformalde-
hyde (Electron Microscopy Sciences, Hatfield, 
PA) for 30 minutes. Flow chambers were then 
rinsed with 50 ml PBS for approximately 30 
minutes before embedding. The embedding 
gel was a 20% 200:1 acrylamide:bis-acrylamide 
polyacrylamide gel that was prepared with 20 
µl of AP S (10 mg/ml), 8 µl TEMED, and 1 ml 
of 20% polyacrylamide 200:1 acrylamide:Bis 
solution. The gel was injected into each flow 
chamber using a 1ml tuberculin syringe. (Bio-
Rad, Hercules, CA) (6, 26). Flow direction was 
marked before the glass which covered each 
chamber was carefully removed and the fixed 
biofilms embedded in the polyacrylaminde gel 
were kept in PBS until stained for microscopy.  
FinalJournal.indd   126 9/25/15   11:38 AM
PATHOGENS AND ANTIMICROBIAL FACTORS• 127
STAINING SAMPLES 
FOR EXAMINATION 
BY CONFOCAL LIGHT 
SCANNING MICROSCOPY:
Cultures of mucoid-like or non-mucoid bac-
terial cells were allowed one hour to attach to 
the surface of poly-L-lysine (Sigma-Aldrich, 
St. Louis, MO) coated cover slips before being 
fixed with 4% paraformaldehyde. Biofilms 
grown in the flow cell apparatus were stained 
through the polyacrylamide gel.  All biofilms 
were stained with a 1:300 dilution of DAPI 
(Invitrogen, Grand Island, NY), which was 
used as a counterstain to label nucleic acids.  
A FITC conjugated antibody to lectin from 
Hippeastrum amaryllis (HHA)  (EY Laborato-
ries, San Mateo, CA, F-8008-1), which binds 
to 1,3- or 1,6- mannosyl units in polysaccha-
rides of the Psl component of the biofilms (25), 
was then applied at 0.2 mg/ml. Slides were 
rinsed, and mounted using an anti-fade reagent 
(ProLong, Life Technologies, Grand Island, 
NY). Flow cell samples were too thick to add 
a coverslip and were maintained under wet 
conditions for microscopy. 
IMAGING OF BIOFILMS 
USING CONFOCAL LASER 
SCANNING MICROSCOPY
A Zeiss LSM 700 confocal laser scanning 
microscope was used to image the previously 
stained bacterial samples for DAPI label of 
nucleic acids or FITC-HHA label of the Psl 
component of PAO1 biofilms.  Single images of 
the biofilms were taken for DAPI or FITC and 
Image J was used to generate composite images 
(30).  Z-stacks were also taken (data not shown) 
and used to give an estimate of biofilm height 
(20). As a negative control coverslips with mu-
coid-like PAO1 were examined without any 
stain or FITC-HHA label. These were viewed 
through the DAPI filter or the FITC filter to 
check for autofluorescence of P. aeruginosa.
MOTILITY ASSAY
Motility assays were conducted as previously 
described (5, 10). Briefly, swim medium con-
tained 0.982% tryptone, 0.295% agarose, and 
0.491% sodium chloride. This is the most fluid 
medium that allows the easiest movement. 
Swarm medium contained 0.786% nutrient 
broth, 0.491% agar, and 0.491% glucose. This 
is a thicker medium that restricts movement. 
Twitch plates contained 0.976% tryptone, 
0.9763% agarose, and 0.976% sodium chloride. 
These plates have the highest concentration of 
agarose and the most restricted movement. 
Non-mucoid and mucoid-like samples for the 
motility assay were prepared as described 
above and given 72 hours to develop. At 72 
hours, an inoculating needle was sterilized in 
alcohol and flame, inserted into the non-mu-
coid or mucoid-like sample just beneath the 
surface of the biofilm, and each motility plate 
was stab inoculated to the bottom of the plate, 
according to Deligianni et al. (10). The point of 
inoculation was marked on the bottom of the 
plate and the plates were incubated at 37°C. 
Growth of colonies was measured 24, 48, or 
72 hours after inoculation; images were taken 
after 48 hours. The sample size was three to 
six plates per time point and plate type. Data 
were analyzed using two comparisons. The 
purpose of the first analysis is to evaluate 
changes in motility over the 72 hour period 
of the motility assay. To do this, values for 
each type of motility (swimming, swarming, 
or twitching), were statistically compared to 
the 24 hour mucoid-like phenotype with an 
unpaired t-test using GraphPad. The second 
analysis determines if there is a difference in 
motility between the two phenotypes at each 
time point. In this analysis, an unpaired t-test 
compared mucoid-like to non-mucoid samples 
at each time point. 
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SURFACE ATTACHMENT 
ASSAY
Surface attachment assays were conducted 
as previously described (21). Briefly, bacterial 
cultures were grown under either mucoid-like 
or non-mucoid conditions for 24, 48, or 72 
hours and then diluted down to an absorbance 
of OD600 of 0.5.  The cultures were then 
diluted 1:2 in TSB and 0.5 ml of each diluted 
culture was placed in an individual well of 
a poly-L-lysine coated 24 well plate for 1.5 
hours. Culture fluid was removed before the 
cultures were fixed with 70% methanol for 30 
minutes and stained with 0.5% crystal violet 
for 30 minutes.  Excess crystal violet was then 
washed from the wells using PBS.  Digital 
images of the plates were obtained.   
NON-MUCOID AND 
MUCOID-LIKE PHENOTYPES
An example of non-mucoid and mucoid-like 
biofilms developed in our lab is shown in Fig. 
1. As can be seen in Fig. 1A, the non-mucoid 
phenotype grown for 72 hours is concen-
trated with a consistent composition. The 
mucoid-like biofilm seen in Fig. 1B has thick, 
mucous-like strings that emanate from the 
surface and spread interior into the TSB. If re-
RESULTS
Figure 1:  Non-mucoid and mucoid-like Pseudomonas aeruginosa biofilm. The non-mucoid 
biofilm (A) was grown in 100 ml TSB in a 250 ml Erlenmeyer flask and has a consistent 
composition. The mucoid-like biofilm (B) was grown in 10 ml TSB in a 16 ml test tube and 
demonstrates strings of mucoid-like biofilm. All samples were incubated at 37°C on a rotary 
shaker at 225 rpm for 72 hours. The specific differences in environment conditions leading 
to the formation of two phenotypes was not investigated. However, studies have shown that 
oxygen deprivation can induce biofilm formation; thus, it is possible the low surface-to-
volume ratio in the test tube may lead to favorable conditions for biofilm development.  
b
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moved from the test tubes, these mucous-like 
strings are easily disrupted and disseminated. 
However, in the test tube, they are discrete 
from the surrounding media. The observation 
of these two phenotypes is the basis of our ex-
amination. When cultured for longer than 72 
hours, PAO1 in the mucoid-like phenotype 
died, perhaps from a lack of nutrients. 
CONFOCAL LASER 
SCANNING MICROSCOPY 
(CLSM)
Fig. 2 A-D demonstrates a composite image 
of a 72 hour mucoid-like biofilm labeled with 
FITC-HHA (A), DAPI (B), and the composite 
image (C). In confocal images of pillar-shaped 
biofilms, it is common to view the EPS matrix 
Figure 2. A-D is an example of a 72 hour mucoid-like biofilm stained with DAPI and HHA-
FITC shown with the FITC filter (A), the DAPI filter (B) and the composite image (C). D is 
the corresponding negative control without DAPI or HHA-FITC antibody. Pockets, indicated 
by dark “holes” within the image, appear to be formed throughout the EPS matrix of the 
biofilm. At these pockets a higher concentration of nucleic acids are present as seen by the 
DAPI fluorescence. These “pockets” filled with PA may be the beginning of pillar-shaped 
biofilms. Scale bars are 25µm. 
a
c d
b
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surrounding a “hollow-like” center that may 
contain bacteria (8). Our biofilms contain 
similar structures. Fig. 2A demonstrates “holes”, 
black spaces in the biofilm surrounded by 
FITC-labeled matrix. These “holes” are, how-
ever, “filled in” with DAPI label in Fig. 2B, in-
dicating that bacteria are within this structure. 
The composite image, Fig. 2C demonstrates the 
separation of the matrix from the bacteria with 
the pattern of blue DAPI stain surrounded by 
the FITC-HHA label for the matrix. Fig. 2D is 
a negative control of mucoid-like PAO1 biofilm 
indicating some background label; however, it 
is much less than the positive label seen in Fig. 
2A-C. 
Figure 3. Confocal microscopy of PA biofilms. PA samples were prepared as described in 
the methods. At 24 hours, all samples demonstrated biofilm growth (A-C). The flow cell 
samples (C) are slanted in the direction of media flow through the chamber and difficult 
to obtain focused images.  At 48 hours, the mucoid-like and flow cell samples demonstrate 
greater growth (D, F) compared to the non-mucoid sample (E). The spherical structures in D 
could be the beginning of pillar-shaped biofilms. In the 72 hour samples (G-I), the mucoid-
like sample (G) shows string-like biofilms structures typical of the mucoid-type phenotype 
compared to the punctate labeling seen in the non-mucoid sample (H). The flow cell sample 
(I) has circular structures indicative of pillar-shaped biofilms.  Calibration bars are 25µm. 
24 hour
mucoid non mucoid flow cell
48 hour
72 hour
a
d
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i
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In order to compare biofilm development 
between the non-mucoid and mucoid-like 
phenotypes generated in this lab, biofilms were 
also grown in once-through flow cell cham-
bers. These chambers have been shown in the 
past to provide optimal conditions for biofilm 
development (3, 29). Fig. 3 compares non-mu-
coid, mucoid-like, and flow cell biofilms 24, 
48, and 72 hours after inoculation of a cham-
ber. Biofilm development was greatest in the 
mucoid-like and flow cell samples at 72 hours 
(Fig. 3G and I). There was some labeling in the 
72 hour non-mucoid sample (Fig. 3H), but it is 
much more punctate and does not show the 
elaborate Psl network seen in the mucoid-like 
or flow-cell apparatus biofilms. 
In Fig. 3I, the 72 hour flow-cell biofilm sample 
demonstrates circular structures similar to the 
pillar shaped biofilms shown in Fig. 2C. The 
mucoid-like biofilms (Fig. 3D, 3G) demonstrate 
biofilm structure that has the Psl matrix as 
observed by the FITC-HHA label, but is not 
always a discrete or circular structure (Fig. 3G). 
However, there is much greater development 
of the Psl matrix than in the non-mucoid 
biofilm which is a more consistent, punctate 
FITC-HHA label indicating a much less com-
plex and fully formed biofilm matrix in the 
non-mucoid sample.  
To measure biofilm height, z-stacks of 72 hour 
samples were used since biofilms at this point 
are the most developed (data not shown). 
Non-mucoid phenotype biofilms were smaller 
and flatter with an average height about 6 µm. 
Mucoid-like phenotype biofilms were taller 
with an average height of 6-12 µm. Flow 
Figure 4. Motility assay.  Shown are images of swim (A-B), swarm (C-D), and twitch 
plates (E-F) for non-mucoid and mucoid phenotypes. All plates were inoculated with 
72 hour samples and allowed to develop for 48 hours. Swarming showed the greatest 
motility of the three types of movement as indicated by the increased diameter. 
All three types of movement demonstrated similar diameters, and therefore similar 
amounts of movement, between the non-mucoid and mucoid-like phenotypes. 
swim
non mucoid
mucoid-like
swarm twitch
a c e
b d f
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cell biofilms were the largest biofilms with 
average heights between 30-40 µm.  Biofilms 
grown in a flow cell chamber were slanted in 
the direction of the flow of media, making it 
difficult to focus the image. 
MOTILITY ASSAY
Fig. 4 A-F demonstrates images of the motil-
ity assays. As can be seen swarming motility 
demonstrated the greatest diameters (Fig. 4 
C, D). Visual inspection alone indicates that 
motility is very similar between PAO1 in each 
phenotype. 
The average movements of swarm motilities 
at 72 hours as shown on the column graphs 
(Fig. 5B) were 18.1 mm (non-mucoid) and 21.8 
mm (mucoid-like) as compared to the swim 
plate values (Fig. 5A) of 16.3 mm (non-mucoid) 
14.6 mm (mucoid-like). Swarming is the only 
motility in which the 72 hour mucoid-like 
biofilm exhibited greater motility as compared 
to the non-mucoid sample (Fig. 5B) although 
there was no statistical difference. It was 
hypothesized that twitching movement would 
be greater in the mucoid-like sample (Fig. 5C); 
however, it was slightly greater in the 72 hour 
non-mucoid sample (12.2 mm vs. 9.5 mm). 
Twitching had the only statistically significant 
data with both the 48 hour non-mucoid and 72 
hour non-mucoid being significantly higher in 
twitching (p = 0.0019 for 48 hour; p = 0.0031 
for 72 hour) than the 24 hour mucoid-like 
phenotype. The 72 hour mucoid-like phe-
notype also demonstrated significantly more 
twitching than the 24 hour mucoid-like sample 
(p = 0.0001). Changes in motility are a part 
of biofilm formation as P. aeruginosa moves 
from swimming to swarming to twitching, 
eventually attaching to a surface and forming 
a microcolony and then a biofilm. Clinical data 
from CF patient sputum indicate that clinical 
isolates containing P. aeruginosa  exhibit wide-
ly varying patterns of motility (10, 27). These 
differences in motility may indicate differences 
in virulence and ability to develop chronic 
Figure 5. Graphs of motility data. A-C are 
graphs of the average diameter for each 
assay. Data were compared to the 24 hour 
mucoid sample for each motility using an 
unpaired t-test (GraphPad). Twitch motility 
demonstrated a significant increase from the 24 
hour sample for the 72 hour mucoid, 48 hour 
non-mucoid, and 72 hour non-mucoid. This 
indicates that over time, both mucoid and non-
mucoid phenotypes exhibited a significant 
increase in twitching. This indicates that both 
phenotypes are exhibiting characteristics 
of biofilm formation; however, the biofilm 
structure between the two phenotypes 
remains different as observed by a flatter 
biofilm structure for non-mucoid biofilms 
using microscopy. Non-mucoid p values: p = 
0.0019, 48 hours; p = 0.0031, 72 hours. Mucoid-
like phenotype p value at 72 hours, p = 0.0001).
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Figure 6. Surface attachment assay.  All samples were given 1.5 hours to attach to the well before 
being fixed and stained with crystal violet. As can be seen, attachment decreased for both 
mucoid-like and non-mucoid samples between 24 and 72 hours. Biofilm formation is usually 
associated with an increase in attachment. While the trend in attachment was not as expected, 
it can be noted that the 72 hour mucoid-like sample exhibited greater punctate staining; these 
punctate areas of staining could be biofilms that attached. There are clearly qualitative differences 
in the development of the mucoid-like phenotype as compared to the non-mucoid phenotype.
24 hour
mucoid-like
non-mucoid
48 hour 72 hour
infections. Motility is now being used as a 
method to further identify and characterize P. 
aeruginosa in sputum from CF patients (10, 27). 
These motility patterns may help identify the 
most effective treatments (27). 
SURFACE ATTACHMENT
Attachment decreased as one moved from 24 
hour to 72 hour samples (Fig. 6). There was a 
qualitative difference in that the mucoid-like 
samples attached with more punctate staining 
indicating clusters or colonies of PAO1 whereas 
the non-mucoid phenotype exhibited a more 
diffuse, even attachment. Each sample was giv-
en 1.5 hours to attach so the punctate staining 
represents clusters of bacteria that existed at the 
time of sample attachment not colonies formed 
through cell division after attachment. The 
clusters may be similar to the circular struc-
tures observed in Fig. 2A-C in which a cluster 
of PAO1 is surrounded by Psl matrix. Absor-
bance data from the surface attachment assays 
did not indicate any significant difference in 
surface attachment when compared to the 24 
hour mucoid-like sample or when comparing 
mucoid-like and non-mucoid samples at each 
time point.  
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DISCUSSION
Biofilm formation is a critical component of 
bacterial infections in a clinical setting; for 
example, in chronic infections in CF that 
increase mortality and morbidity (17). Biofilms 
are also implicated in chronic sinusitis and 
chronic wounds as well as other infections (4). 
It is well documented that mucoid biofilms 
are more pathogenic (11, 23). Alginate, one of 
the prime components of a mucoid bio-
film elicits different responses from airway 
epithelium that attenuates the host response 
(7). It is also well documented that biofilms 
isolated from clinical patients exhibit widely 
different morphology and physiology with 
some forming pillar-shaped biofilms, some 
forming knobby shaped biofilms, and some 
with flat biofilms (10, 27). Motility assays are 
one way in which clinical strains are analyzed 
to determine trends in pathogenicity. Multiple 
studies using motility assays have found that 
pathogenic strains have decreased motility (1, 
27).
The classic biofilm structure is that of a pil-
lar-shaped structure containing bacteria and 
surrounded by an exopolymeric substance 
(EPS) composed of Psl, Pel, and alginate. It is 
hypothesized that biofilm formation may be 
driven by environmental conditions such as 
nutrient depletion, although the environmen-
tal triggers driving biofilm formation are not 
completely understood (1, 4, 7). A common 
way in which biofilms are grown within the 
lab is with rotation in a shaker, similar to the 
non-mucoid phenotype in this study using 
an Erlenmeyer flask. This biofilm produces 
different ratios of quorum-sensing molecules 
than biofilms formed within patient sputum 
(33). The environmental conditions that trigger 
biofilm transformation from a non-mucoid to 
a mucoid phenotype remain unknown (7).
Our lab was able to grow two distinct pheno-
types of PAO1 biofilms under two environ-
mental conditions that may include oxygen 
or nutrient deprivation. It was our hypothesis 
that PAO1 in the mucoid-like phenotype 
would produce a biofilm closer to a clini-
cal “mucoid” biofilm with greater twitching 
motility, greater attachment to a surface, and 
greater height and pillar-shaped structure 
when compared to the non-mucoid pheno-
type of PAO1. 
Based on our data, both phenotypes exhibit 
some markers of biofilm development such 
as increased twitching behavior by PAO1 as 
well as a clearly defined matrix, indicated 
by FITC-HHA labeling. However, the mu-
coid-like phenotype exhibits characteristics 
closer to the more fully formed, mature 
pillar-shaped biofilms described in literature 
(8, 10). The mucoid-like biofilm developing in 
our lab had evidence of small pillar-shaped 
structures that were beginning to form (Fig. 2 
A-C), but did not reach the height or com-
plexity of biofilms formed in a flow-through 
chamber (Fig. 3G and 3I).  
Biofilms are associated with a decrease in 
motility, both swimming and swarming (10, 
27). Swimming utilizes flagella to propel 
bacteria to a new location, possibly to obtain 
a better food source. Twitching utilizes type 
IV pili to slowly move across a surface and 
is associated with surface attachment and 
the beginning stages of biofilm formation. 
Swarming is one of several intermediate 
forms of motility that utilizes both flagella 
and type IV pili as well as a bacterial-secreted 
rhamnolipid that acts as a surfactant to create 
a more fluid surface for bacterial movement 
(5, 22, 35). PAO1 in our mucoid-like pheno-
type exhibited swimming and swarming 
at 24, 48, and 72 hour time points (Fig. 4F); 
however, the only significant differences 
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in motility when compared to the 24 hour 
mucoid-like phenotype were in twitching. At 
both 48 hours and 72 hours the non-mucoid 
phenotype had significantly greater twitching 
than the 24 hour mucoid-like phenotype (Fig. 
5C, p = 0.0019, 48 hours; p = 0.0031, 72 hours). 
At 72 hours, the mucoid-like phenotype had 
significantly greater twitching than the 24 
hour mucoid-like (Fig. 5C, p = 0.0001). These 
data signal an increase in twitching across a 
72 hour period and support that both of these 
phenotypes may be progressing through the 
early stages of biofilm development.  
Surface attachment is also an established and 
necessary component for biofilm formation 
(8, 17). This may be facilitated by a switch 
from swimming motility to swarming and 
then to twitching as the bacteria become sed-
entary. In our phenotypes, attachment consis-
tently decreased from 24 to 72 hours in both 
the mucoid-like and non-mucoid phenotypes. 
This is counter to the generally accepted view 
that surface attachment of bacteria increases 
as biofilms form. However, there were also 
qualitative differences, especially in the mu-
coid-like phenotype which exhibited more 
punctate staining. These punctate spots could 
be small biofilms (Fig. 6) which would be 
consistent with biofilm formation. 
In conclusion, our data indicate both pheno-
types are in the process of biofilm forma-
tion due to FITC-HHA label and increased 
twitching. However, there are also differ-
ences between the phentoypes as shown 
in CLSM images in which the mucoid-like 
biofilm has more pillar-shaped biofilms and 
in the increased level of punctate staining in 
the surface attachment assay.   Not much is 
known about the environmental factors that 
drive the formation of the wide variety of 
biofilms observed in clinical isolates. Nutrient 
and oxygen deprivation have been implicated 
in the formation of mucoid-like biofilms (16, 
32, 37). The role of specific environmental 
triggers was not investigated in this study; 
however, knowing that environments as 
simple as using a test tube or an Erlenmeyer 
flask can produce two different phenotypes 
of biofilms might lead to further identification 
of the triggers that lead to the development of 
pathogenic biofilms in patients.
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